nevirapine has been researched along with Thyroid Neoplasms in 6 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor used in HIV patients and recently evaluated as a differentiating and antiproliferative agent in human malignancies." | 2.73 | Nevirapine toxicity in non-HIV cancer patients. ( Barone, C; Cignarelli, M; De Vis, K; Fabiano, A; Fersini, A; Landriscina, M; Lombardi, V; Piscazzi, A; Santodirocco, M, 2008) |
| "Nevirapine has been proved to suppress tumor growth and induce differentiation in several tumor cells, but has not previously been evaluated in metastasis of thyroid cancer." | 1.51 | Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells. ( Dong, J; Liao, L; Shang, H; Wang, H; Wang, S; Yao, J; Zhao, J, 2019) |
| "In dedifferentiated thyroid cancer, they reestablish thyroid-stimulating hormone (TSH) signaling, Na/I symporter (NIS), thyroglobulin peroxidase (TPO) expression, and even radioiodine uptake (RIU)." | 1.34 | Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine. ( Ambrosi, A; Cignarelli, M; Fabiano, A; Fersini, A; Landriscina, M; Modoni, S; Urbano, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shang, H | 1 |
| Zhao, J | 1 |
| Yao, J | 1 |
| Wang, H | 1 |
| Wang, S | 1 |
| Dong, J | 1 |
| Liao, L | 3 |
| Dong, JJ | 2 |
| Zhou, Y | 2 |
| Liu, YT | 1 |
| Zhang, ZW | 2 |
| Zhou, XJ | 1 |
| Wang, HJ | 2 |
| Landriscina, M | 3 |
| Fabiano, A | 3 |
| Lombardi, V | 1 |
| Santodirocco, M | 1 |
| Piscazzi, A | 1 |
| Fersini, A | 3 |
| De Vis, K | 1 |
| Barone, C | 2 |
| Cignarelli, M | 3 |
| Modoni, S | 2 |
| Ambrosi, A | 2 |
| Urbano, N | 1 |
1 trial available for nevirapine and Thyroid Neoplasms
| Article | Year |
|---|---|
Nevirapine toxicity in non-HIV cancer patients.
Topics: Aged; HIV Infections; Humans; Middle Aged; Neoplasm Staging; Nevirapine; Thyroid Neoplasms | 2008 |
5 other studies available for nevirapine and Thyroid Neoplasms
| Article | Year |
|---|---|
Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biopsy; Cell Line, Tumor; Cell Movement; Cell Proliferati | 2019 |
In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Iodine Radioisotopes | 2013 |
[Influences of nevirapine on cell proliferation and expression of sodium/iodide symporter in human anaplastic thyroid carcinoma cell line].
Topics: Cell Line, Tumor; Cell Proliferation; Humans; Nevirapine; Receptors, Thyrotropin; Symporters; Thyroi | 2012 |
Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine.
Topics: Aged; Carcinoma, Papillary; Cell Differentiation; Cells, Cultured; Female; Fluorescent Antibody Tech | 2006 |
Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
Topics: Aged; Biopsy, Fine-Needle; Cell Differentiation; Cell Shape; Female; Humans; Iodine Radioisotopes; L | 2007 |